Fibronectin in Cancer: Friend or Foe
Open Access
Abstract
The role of fibronectin (FN) in tumorigenesis and malignant progression has been highly controversial. Cancerous FN plays a tumor-suppressive role, whereas it is pro-metastatic and associated with poor prognosis. Interestingly, FN matrix deposited in the tumor microenvironments (TMEs) promotes tumor progression but is paradoxically related to a better prognosis. Here, we justify how FN impacts tumor transformation and subsequently metastatic progression. Next, we try to reconcile and rationalize the seemingly conflicting roles of FN in cancer and TMEs. Finally, we propose future perspectives for potential FN-based therapeutic strategies.Keywords
This publication has 365 references indexed in Scilit:
- The IL-6 Trans-Signaling-STAT3 Pathway Mediates ECM and Cellular Proliferation in Fibroblasts from Hypertrophic ScarJournal of Investigative Dermatology, 2013
- S1PR1-STAT3 Signaling Is Crucial for Myeloid Cell Colonization at Future Metastatic SitesCancer Cell, 2012
- EMT and Dissemination Precede Pancreatic Tumor FormationCell, 2012
- Macrophage Diversity Enhances Tumor Progression and MetastasisCell, 2010
- IAP Regulation of MetastasisCancer Cell, 2010
- Modeling Inducible Human Tissue Neoplasia Identifies an Extracellular Matrix Interaction Network Involved in Cancer ProgressionCancer Cell, 2009
- Hypoxia-Induced Lysyl Oxidase Is a Critical Mediator of Bone Marrow Cell Recruitment to Form the Premetastatic NicheCancer Cell, 2009
- TGFβ in CancerCell, 2008
- TGFβ Primes Breast Tumors for Lung Metastasis Seeding through Angiopoietin-like 4Cell, 2008
- A negative feedback signaling network underlies oncogene-induced senescenceCancer Cell, 2006